Join to access to all OVN content. Join for Free
Leveraging Creativity to Break into Your First MSL Role
Provide 5 keywords for SEO search separated by commas

Leveraging Creativity to Break into Your First MSL Role


Share This Article


Summary

In this episode, Alec McCarthy shares his insights on breaking into the MSL field with a creative approach. He highlights the 70/30 rule for networking, emphasizing its importance for early-career professionals, and recounts his own journey to securing an MSL position. The discussion covers strategies for effective messaging, particularly when engaging with C-suite executives, and the value of LinkedIn Premium for MSLs. Alec also explores using publishing and scientific literature to enhance job applications, aligning work with personal values, and the significance of persistence and resilience in the job search. The episode concludes with actionable advice for aspiring MSLs.

My guest today is Alec McCarthy, Medical Science Liaison at Merz Asthetics, and we discuss how to leverage creativity to break into your first MSL role.

Alec shares…

πŸ‘‰ What the 70/30 rule is and what the process is about
πŸ‘‰ What is important for aspiring MSLs to get noticed
πŸ‘‰ How to approach companies that you are targeting
πŸ‘‰ What tools and resources to rely on during the search process
πŸ‘‰ Creative tips

Click for Source
Provide 5 keywords for SEO search separated by commas

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Start a Diversity Equity & Inclusion Program in Pharma
Partner Avatar MSL Talk: Tom Caravela, Tara Gonzalez

How to Start a Diversity Equity & Inclusion Program in Pharma

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Explore OVN